Abstract
Although spontaneous remissions are frequent in sarcoidosis, chronic persistent disabling disease is also observed. This feature seems more frequent and more severe in black patients, as has been previously reported (10). The more extensive and severe the initial disease manifestations, the more likely it is that the disease will continue. Corticosteroids are usually beneficial and complications are infrequent. Delayed or interrupted treatment seems to allow progression or irreversible disease or both. Patient compliance is an obvious important factor. Relapses are frequent as treatment is withdrawn but are usually at least partially reversible. Some deterioration is observed with repeated relapses. Low dose daily prednisone (5-15 mg) seems to prevent relapses. Patient compliance is facilitated with daily treatment rather than alternate day therapy. Prolonged treatment for 10 to 15 or more years is often required. Chloroquine is particularly helpful in skin and mucosal disease. The necessity for long-term thoughtful management is obvious.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Johns C. J., Macgregor M. I., Zachary J. B., Ball W. C. Extended experience in the long-term corticosteroid treatment of pulmonary sarcoidosis. Ann N Y Acad Sci. 1976;278:722–731. doi: 10.1111/j.1749-6632.1976.tb47087.x. [DOI] [PubMed] [Google Scholar]
- Kaplan J., Johns C. J. Mycetomas in pulmonary sarcoidosis: non-surgical management. Johns Hopkins Med J. 1979 Oct;145(4):157–161. [PubMed] [Google Scholar]
- LONGCOPE W. T., FREIMAN D. G. A study of sarcoidosis; based on a combined investigation of 160 cases including 30 autopsies from The Johns Hopkins Hospital and Massachusetts General Hospital. Medicine (Baltimore) 1952 Feb;31(1):1–132. [PubMed] [Google Scholar]
- MAYOCK R. L., BERTRAND P., MORRISON C. E., SCOTT J. H. MANIFESTATIONS OF SARCOIDOSIS. ANALYSIS OF 145 PATIENTS, WITH A REVIEW OF NINE SERIES SELECTED FROM THE LITERATURE. Am J Med. 1963 Jul;35:67–89. doi: 10.1016/0002-9343(63)90165-7. [DOI] [PubMed] [Google Scholar]
- Sartwell P. E. Racial differences in sarcoidosis. Ann N Y Acad Sci. 1976;278:368–370. doi: 10.1111/j.1749-6632.1976.tb47047.x. [DOI] [PubMed] [Google Scholar]
- Thomas C. B., Duszynski K. R. Closeness to parents and the family constellation in a prospective study of five disease states: suicide, mental illness, malignant tumor, hypertension and coronary heart disease. Johns Hopkins Med J. 1974 May;134(5):251–270. [PubMed] [Google Scholar]
- Wurm K., Rosner R. Prognosis of chronic sarcoidosis. Ann N Y Acad Sci. 1976;278:732–735. doi: 10.1111/j.1749-6632.1976.tb47088.x. [DOI] [PubMed] [Google Scholar]